Skip to main content

Synthesis and Anti-HIV-Evaluation of Novel Andrographolide Derivatives

Buy Article:

$68.00 + tax (Refund Policy)

A series of Andrographolide derivatives were described and evaluated for their in vitro anti-HIV activity. Compound 11 and 21 showed significant anti-HIV-1 activity in C8166 cells. Since compound 11 had no cytotoxicity, it was expected to be new lead for further development of anti-AIDS agents.

Keywords: Acquired immune deficiency syndrome; Andrographolide; Anti-HIV; C8166 cells; Derivatives; Natural products; RDCSY- I capillary apparatus; Synthesis; human immunodeficiency virus; lymphocyte counts

Document Type: Research Article

Publication date: 01 February 2013

More about this publication?
  • Letters in Drug Design & Discovery publishes original letters on all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of Internet technology for both the submission and review of manuscripts. The journal is essential reading to all pharmaceutical scientists involved in research in drug design and discovery.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content